Journal of Pediatric Epilepsy 2013; 02(02): 097-107
DOI: 10.3233/PEP-13048
Review Article
Georg Thieme Verlag KG Stuttgart – New York

Corticosteroid therapy for epileptic encephalopathies other than West syndrome

Serena Donetti Dontin
a   Department of Child Neurology and Psychiatry, Fondazione IRCCS Istituto Neurologico Nazionale Casimiro Mondino, Pavia, Italy
,
Sara Olivotto
a   Department of Child Neurology and Psychiatry, Fondazione IRCCS Istituto Neurologico Nazionale Casimiro Mondino, Pavia, Italy
,
Federica Teutonico
a   Department of Child Neurology and Psychiatry, Fondazione IRCCS Istituto Neurologico Nazionale Casimiro Mondino, Pavia, Italy
,
Nausicaa Altieri
a   Department of Child Neurology and Psychiatry, Fondazione IRCCS Istituto Neurologico Nazionale Casimiro Mondino, Pavia, Italy
,
Umberto Balottin
a   Department of Child Neurology and Psychiatry, Fondazione IRCCS Istituto Neurologico Nazionale Casimiro Mondino, Pavia, Italy
,
Pierangelo Veggiotti
a   Department of Child Neurology and Psychiatry, Fondazione IRCCS Istituto Neurologico Nazionale Casimiro Mondino, Pavia, Italy
› Author Affiliations

Subject Editor:
Further Information

Publication History

12 December 2012

30 January 2013

Publication Date:
18 July 2015 (online)

Abstract

Epileptic encephalopathies are age-dependent conditions, typically drug resistant, characterized by severe cognitive impairment due to the epileptic activity itself. Corticosteroid therapy with adrenocorticotrophic hormone, hydrocortisone, prednisone or methylprednisolone is one of the therapeutic approaches tried in these children. Although the first use of steroids as antiepileptic drugs dates back to 1950, there is no wide agreement about the ideal treatment regimen in epileptic encephalopathies other than West syndrome; no evidence from class I and II studies are available at the moment. In this study, we present a literature review on steroid therapy in childhood epilepsy with special regard to effectiveness, tolerability and possible mechanisms of action.